Investing.com - argenx ADR reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
argenx ADR announced earnings per share of $-4.36 on revenue of $31.48M. Analysts polled by Investing.com anticipated EPS of $-5.03 on revenue of $15.71M.
argenx ADR shares are up 31.27% from the beginning of the year and are trading at $292.93 , down-from-52-week-high.They are outperforming the Nasdaq which is down 17.13% from the start of the year.
argenx ADR follows other major Healthcare sector earnings this month
argenx ADR's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar